Add to ORKGRivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atrial fibrillation who developed rectus sheath hematoma and retroperitoneal bleeding. DOI: https://dx.doi.org/10.4314/ahs.v19i2.55 Cite as: B\uf6rekci E. Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report. Afri Health Sci.2019;19(2): 2290-2293. https://dx.doi.org/10.4314/ahs.v19i2.5
Introduction: Early prophylactic administration of anticoagulants is recommended in patients with co...
Rivaroxaban is a newer anticoagulant initially approved by the Food and Drug Administration to treat...
Rectus sheath hematoma is a rare but potentially life-threatening complication following any major a...
Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath ...
Apixaban is an oral anticoagulant that directly inhibits Factor Xa and is indicated for the prophyla...
Rectus sheath hematoma is a rare complication of anticoagulant therapy. We have described the case o...
Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of us...
AbstractIntroductionWe present a case of a presacral hematoma, which penetrated into the rectum resu...
A 67-year-old woman was admitted to hospital with shortness of breath and acute cough for two days. ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Bleeding from enoxaparin is a recognized side effect; however, the formation of rectus sheath and re...
We reported two cases of retroperitoneal hematoma in patients who received a combination of anticoag...
Rectal sheath hematoma has been a well-known clinical entity from the ruin of the ancient Greece. It...
Background/Purpose Rectus sheath hematoma (RSH) is a rare clinical entity. It can be mistaken for ot...
AbstractRectus sheath hematoma (RSH) is an accumulation of blood in the rectus abdominis muscle shea...
Introduction: Early prophylactic administration of anticoagulants is recommended in patients with co...
Rivaroxaban is a newer anticoagulant initially approved by the Food and Drug Administration to treat...
Rectus sheath hematoma is a rare but potentially life-threatening complication following any major a...
Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath ...
Apixaban is an oral anticoagulant that directly inhibits Factor Xa and is indicated for the prophyla...
Rectus sheath hematoma is a rare complication of anticoagulant therapy. We have described the case o...
Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of us...
AbstractIntroductionWe present a case of a presacral hematoma, which penetrated into the rectum resu...
A 67-year-old woman was admitted to hospital with shortness of breath and acute cough for two days. ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Bleeding from enoxaparin is a recognized side effect; however, the formation of rectus sheath and re...
We reported two cases of retroperitoneal hematoma in patients who received a combination of anticoag...
Rectal sheath hematoma has been a well-known clinical entity from the ruin of the ancient Greece. It...
Background/Purpose Rectus sheath hematoma (RSH) is a rare clinical entity. It can be mistaken for ot...
AbstractRectus sheath hematoma (RSH) is an accumulation of blood in the rectus abdominis muscle shea...
Introduction: Early prophylactic administration of anticoagulants is recommended in patients with co...
Rivaroxaban is a newer anticoagulant initially approved by the Food and Drug Administration to treat...
Rectus sheath hematoma is a rare but potentially life-threatening complication following any major a...